S&P 500 7,609.78 +0.13% NASDAQ 27,093.90 +0.03% DOW 51,307.79 +0.45% R2K 2,931.96 +0.90% VIX 16.10 +2.09%
Next Bullish Trade
JNJ Johnson & Johnson NYQ
$222.89 -0.62 (-0.28%)
Pullback · -1.26σ Grade C
+ Compare Set alert Open in Sniper

Price chart

Overlay: Click earnings ▲ markers for day-move details

Loading 1Y daily…

Financial overlay · last 12 quarters

QuarterRevenue Net incomeOp income FCFNet margin Op margin
2026-03-31 $24.1B $5.2B $6.4B $1.5B 21.8% 26.6%
2025-12-31 $24.6B $5.1B $5.6B $5.5B 20.8% 22.8%
2025-09-30 $24.0B $5.2B $7.1B $8.0B 21.5% 29.6%
2025-06-30 $23.7B $5.5B $6.7B $2.5B 23.3% 28.3%
2025-03-31 $21.9B $11.0B $6.2B $3.4B 50.2% 28.3%
2024-12-31 $nanB $nanB $nanB $nanB nan% nan%
2024-09-30 $nanB $nanB $nanB $nanB nan% nan%

Earnings replay · last 20 reports

DateEPS actual EPS estSurprise
2026-04-14 2.14 2.27 -5.9%
2026-01-21 2.46 2.46 -0.1%
2025-10-14 2.80 2.76 +1.5%
2025-07-16 2.77 2.68 +3.2%
2025-04-15 4.54 2.26 +100.9%
2025-01-22 2.04 2.01 +1.4%
2024-10-15 2.42 2.21 +9.7%
2024-07-17 2.82 2.70 +4.3%
2024-04-16 2.71 2.65 +2.3%
2024-01-23 2.29 2.28 +0.4%
2023-10-17 2.66 2.52 +5.5%
2023-07-20 2.80 2.62 +6.9%
2023-04-18 2.68 2.50 +7.2%
2023-01-24 2.35 2.24 +5.1%
2022-10-18 2.55 2.49 +2.6%
2022-07-19 2.59 2.55 +1.6%
2022-04-19 2.67 2.57 +4.1%
2022-01-25 2.13 2.12 +0.5%
2021-10-19 2.60 2.35 +10.5%
2021-07-21 2.48 2.28 +8.6%

Earnings markers are overlaid on the price chart above. Transcript summaries require PERPLEXITY_API_KEY (deferred to a follow-up).

Peer comparison · Healthcare

Ticker ⇅ Mkt cap ⇅ P/E ⇅ Fwd P/E ⇅ P/S ⇅ EV/EBITDA ⇅ P/B ⇅ Gross M ⇅ Rev gr ⇅ EPS gr ⇅ FCF yld ⇅
LLY $949B 37.7 23.9 13.1 27.3 30.5 82.8% 55.5% 169.9% 0.96%
UNH $343B 28.5 18.1 0.8 18.5 3.5 18.8% 2.0% 0.7% 5.15%
JNJ ★ $537B 25.8 17.5 5.6 16.6 6.6 68.0% 9.9% -52.9% 2.33%
MRK $286B 32.6 12.1 4.3 11.2 6.2 76.7% 4.9% — 4.92%
ABBV $381B 105.1 13.3 6.1 14.8 -57.2 72.0% 12.4% -46.2% 5.47%
PFE $146B 19.5 9.0 2.3 7.8 1.6 74.8% 5.4% -10.1% 8.50%
TMO $179B 26.5 17.7 4.0 19.4 3.4 40.9% 6.2% 11.3% 3.08%
ABT $151B 24.4 14.3 3.4 15.2 2.9 56.5% 7.8% -19.7% 4.19%

Auto-seeded from sector. Click any ticker to switch.

Ownership

Top institutional holders

Top-10 concentration: 34.08%

HolderShares% out
Blackrock Inc. 213,385,546 8.86%
Vanguard Capital Management LLC 156,605,370 6.51%
State Street Corporation 133,476,288 5.54%
Vanguard Portfolio Management LLC 63,514,436 2.64%
JPMORGAN CHASE & CO 63,096,344 2.62%
Geode Capital Management, LLC 59,164,862 2.46%
Morgan Stanley 44,721,167 1.86%
State Farm Mutual Automobile Insuran 31,590,952 1.31%
Northern Trust Corporation 29,319,669 1.22%
Bank of America Corporation 25,516,697 1.06%

Insider activity · 90d

No insider trades for JNJ in last 90d.

Analyst estimates

yfinance
Low
$155.0
Mean
$252.86957
High
$285.0
Analysts
23

Consensus: buy (mean 2.0). Distribution requires FINNHUB_API_KEY.

SEC filings

FormFiled DescriptionAction
13F-HR 2026-05-13 Institutional holdings (13F) view ·
4 2026-05-04 FORM 4 view ·
8-K 2026-04-28 8-K view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
4 2026-04-27 FORM 4 view ·
10-Q 2026-04-22 10-Q view ·
8-K 2026-04-14 8-K view ·
4 2026-03-12 FORM 4 view ·
4 2026-03-12 FORM 4 view ·
4 2026-03-12 FORM 4 view ·
DEF 14A 2026-03-11 DEF 14A view ·
4 2026-03-03 FORM 4 view ·
4 2026-02-23 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
4 2026-02-18 FORM 4 view ·
13F-HR 2026-02-13 Institutional holdings (13F) view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
4 2026-02-11 FORM 4 view ·
10-K 2026-02-11 10-K view ·
4 2026-02-10 FORM 4 view ·
4 2026-02-09 FORM 4 view ·
4 2026-02-09 FORM 4 view ·
4 2026-02-06 FORM 4 view ·
4 2026-01-28 FORM 4 view ·
8-K 2026-01-21 8-K view ·
4 2025-12-11 FORM 4 view ·
4 2025-12-11 FORM 4 view ·
4 2025-12-11 FORM 4 view ·
4 2025-12-01 FORM 4 view ·
4 2025-12-01 4 view ·
4 2025-11-25 4 view ·
4 2025-11-14 4 view ·
13F-HR 2025-11-13 Institutional holdings (13F) view ·
4 2025-11-10 4 view ·

About

Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of a range of products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as oncology, immunology, neuroscience, pulmonary hypertension, infectious diseases, and cardiovascular and metabolism distributed through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides a portfolio of products used in the surgery, orthopedic, cardiovascular, and vision fields distributed through wholesalers, hospitals and retailers, and used in the professional fields by physicians, nurses, hospitals, eye care professionals and clinics. This segment also offers products and enabling technologies that support joint reconstruction, trauma, spine, sports related injuries, and others, as well as open, laparoscopic, and robotic surgical procedures; instrumentation, energy devices, stapling systems, wound closure, biosurgery products, and digital and robotic technologies; breast aesthetics and re…